Header Logo

Connection

PARTOW KEBRIAEI to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications PARTOW KEBRIAEI has written about Radiopharmaceuticals.
PARTOW KEBRIAEI
Connection Strength
0.013
Radiopharmaceuticals
  1. Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation. Br J Haematol. 2008 Sep; 142(5):786-92.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.